Can Stimulants Exacerbate Trichotillomania?
Stimulants can potentially trigger or exacerbate trichotillomania in some patients, though this appears to be a rare adverse effect, and the evidence suggests that in patients with comorbid ADHD and trichotillomania, stimulant treatment does not typically worsen hair-pulling symptoms.
Evidence from FDA Drug Labeling
The FDA-approved labeling for mixed amphetamine salts does not list trichotillomania as a recognized adverse effect, though it does warn about motor and verbal tics and worsening of Tourette's syndrome 1. The label specifically advises patients to "notify their healthcare provider if emergence or worsening of tics or Tourette's syndrome occurs" 1.
Case Reports of Stimulant-Induced Trichotillomania
Several case reports document new-onset trichotillomania following stimulant initiation:
Amphetamine salts: A 12-year-old girl developed trichotillomania shortly after starting Adderall, with complete resolution after switching to guanfacine 2. This represents an unusual but documented adverse effect.
Methylphenidate and lisdexamfetamine: Two pediatric cases showed new-onset trichotillomania during treatment with these agents 3.
Adult case: One adult with ADHD developed trichotillomania coinciding with amphetamine abuse, which resolved with discontinuation and olanzapine initiation 4.
These cases suggest a temporal relationship between stimulant exposure and trichotillomania onset in susceptible individuals.
Evidence in Patients with Comorbid ADHD and Trichotillomania
Importantly, the most recent and robust evidence contradicts concerns about stimulants worsening pre-existing trichotillomania:
In a 2022 study of 308 adults with trichotillomania, 15.3% had comorbid ADHD 5. Critically, participants taking stimulant medications for ADHD did not show increased trichotillomania severity compared to those not taking stimulants 5.
A 2011 study of 9 pediatric patients with both ADHD and trichotillomania treated with methylphenidate for 12 weeks showed significant ADHD improvement without significant worsening of hair-pulling symptoms 6. However, patients with higher rates of stressful life events showed less response 6.
Clinical Recommendations
When prescribing stimulants, consider the following algorithm:
Screen for pre-existing trichotillomania or other body-focused repetitive behaviors before initiating stimulant therapy 1.
In patients with comorbid ADHD and trichotillomania: Stimulants remain appropriate first-line treatment for ADHD, as evidence suggests they do not typically worsen hair-pulling 5, 6. The benefits of treating ADHD likely outweigh the minimal risk of exacerbating trichotillomania.
Monitor for new-onset or worsening hair-pulling behaviors during the first weeks to months of stimulant treatment, particularly in children and adolescents 3, 2.
If trichotillomania emerges or worsens after stimulant initiation:
Document the temporal relationship between stimulant initiation/dose changes and any hair-pulling symptoms to establish causality 3, 2, 4.
Important Caveats
The risk of stimulant-induced trichotillomania appears rare based on case report frequency relative to widespread stimulant use 5, 3, 2, 4.
Methylphenidate may have a different risk profile than amphetamines for psychiatric adverse effects, as one study found no increased odds of psychosis or mania with methylphenidate compared to significant risk with amphetamines 8.
The mechanism may involve dopaminergic effects, as both ADHD and trichotillomania implicate dopamine dysfunction 6.
Do not withhold necessary ADHD treatment in patients with pre-existing trichotillomania based solely on theoretical concerns, as real-world evidence does not support routine worsening 5.